HuGE Literature Finder
Records 1-5
Effect of Sofosbuvir Plus Daclatasvir in Hepatitis C Virus Genotype-4 Patients: Promising Effect on Liver Fibrosis.
Journal of clinical and experimental hepatology 2018 Mar 8 (1): 15-22. Abdel-Aziz Asmaa M, Ibrahim Mohamed A, El-Sheikh Azza A, Kamel Maha Y, Zenhom Nagwa M, Abdel-Raheim Salam, Abdelhaleem Hish |
Association of genetic variants in the interleukin-18 gene promoter with risk of hepatocellular carcinoma and metastasis in patients with hepatitis C virus infection.
IUBMB life 2018 02 70 (2): 165-174. Bakr Noha M, Awad Ashraf, A Moustafa Em |
T helper cell?related cytokine gene polymorphisms and vitamin D pathway gene polymorphisms as predictors of survival probability in patients on renal replacement therapy.
Polskie Archiwum Medycyny Wewn?trznej 2015 Aug 125 (7-8): 511-20. ?widerska Monika, Mostowska Adrianna, Grzegorzewska Alicja |
Interleukin 18 promoter variants (-137G>C and -607C>A) in patients with chronic hepatitis C: association with treatment response.
Journal of clinical immunology 2009 Sep 29 (5): 620-8. Haas Stephan L, Weiss Christel, Bugert Peter, Gundt Jutta, Witt Heiko, Singer Manfred V, Berg Thomas, Böcker Ulri |
Regulatory polymorphisms in the interleukin-18 promoter are associated with hepatitis C virus clearance.
The Journal of infectious diseases 2008 Oct 198 (8): 1159-65. An Ping, Thio Chloe L, Kirk Gregory D, Donfield Sharyne, Goedert James J, Winkler Cheryl |
- Page last reviewed:Oct 1, 2020
- Page last updated:Apr 08, 2021
- Content source: